8.10
Avantor Inc stock is traded at $8.10, with a volume of 14.64M.
It is up +3.18% in the last 24 hours and up +6.72% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$7.85
Open:
$7.86
24h Volume:
14.64M
Relative Volume:
1.34
Market Cap:
$5.48B
Revenue:
$6.55B
Net Income/Loss:
$-551.40M
P/E Ratio:
-10.02
EPS:
-0.8082
Net Cash Flow:
$438.90M
1W Performance:
+4.38%
1M Performance:
+6.72%
6M Performance:
-26.70%
1Y Performance:
-37.64%
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AVTR
Avantor Inc
|
8.10 | 5.31B | 6.55B | -551.40M | 438.90M | -0.8082 |
|
ISRG
Intuitive Surgical Inc
|
457.61 | 165.27B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
149.04 | 42.53B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
44.47 | 37.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ALC
Alcon Inc
|
74.87 | 36.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
213.81 | 31.63B | 5.40B | 1.49B | 1.78B | 10.12 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible - Seeking Alpha
Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline - Yahoo! Finance Canada
Avantor, Inc. (AVTR) Q1 earnings and revenues top estimates - MSN
Avantor stock up as new lab capabilities improve biopharma support - MSN
Avantor Expands Masterflex Brand Across Fluid Handling Portfolio - MyChesCo
Avantor, Inc. (NYSE:AVTR) Q1 2026 Earnings Call Transcript - Insider Monkey
Avantor Q1 Earnings Call Highlights - Yahoo Finance
Avantor Reports "Turning Point" in Q1 2026 as Revival Transformation Begins to Deliver - Lab Manager
Vanguard holds 35.8M shares of Avantor (AVTR) in Schedule 13G - Stock Titan
Avantor forecasts Q2 adjusted EPS of $0.19-$0.20 while incorporating $10M-$20M inflation headwind - MSN
Avantor, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Avantor shares jump 9% after Q1 earnings beat - MSN
Avantor, Inc. Q1 2026 Financial Results, Risk Factors, and Forward-Looking Statements – SEC Form 10-Q Highlights - Minichart
Avantor Q1 2026 slides show turnaround progress, stock surges 10% - Investing.com
Earnings call transcript: Avantor Q1 2026 beats expectations, stock surges - Investing.com
Avantor 10-Q: Revenue $1,581.4M, EPS $0.06 — Quarterly results - TradingView
Transcript: Avantor Q1 2026 Earnings Conference Call - Benzinga
[10-Q] Avantor, Inc. Quarterly Earnings Report - Stock Titan
Avantor, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:AVTR) 2026-04-29 - Seeking Alpha
Avantor’s (NYSE:AVTR) Q1 CY2026 Sales Beat Estimates - StockStory
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Avantor (AVTR) Surges After Smashing Q1 Estimates - ChartMill
Avantor stock surges 9% on first quarter earnings beat By Investing.com - Investing.com Australia
Avantor stock surges 9% on first quarter earnings beat - Investing.com
Earnings Flash (AVTR) Avantor, Inc. Reports Q1 Revenue $1.58B, vs. FactSet Est of $1.54B - marketscreener.com
Earnings Flash (AVTR) Avantor, Inc. Posts Q1 Adjusted EPS $0.17 per Share, vs. FactSet Est of $0.16 - marketscreener.com
Avantor reports Q1 2026: $1.58B sales, $43.3M net income, $0.17 adjusted EPS - TradingView
Profits fall as Avantor (NYSE: AVTR) keeps 2026 outlook - Stock Titan
Avantor® Reports First Quarter 2026 Results - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR - The National Law Review
Avantor Q1 2026 earnings preview - MSN
Avantor earnings on deck as Revival turnaround faces test By Investing.com - Investing.com Nigeria
Avantor earnings on deck as Revival turnaround faces test - Investing.com
Avantor (AVTR) Q1 Earnings: What To Expect - Yahoo Finance
Avantor shares sink 14% after Q3 earnings miss and $785M impairment charge - MSN
Here's why you should hold Avantor stock in your portfolio for now - msn.com
Avantor rallies as Engine Capital takes 3% stake, pushes for strategy to double stock - msn.com
Avantor slips after adjusted profit miss - msn.com
Avantor, Inc. (AVTR) Stock Analysis: Evaluating The 33.89% Potential Upside - DirectorsTalk Interviews
Avantor Q4 2025 earnings preview - msn.com
Avantor shares drop more than 5% as turnaround efforts fail to excite investors - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Avantor expands Masterflex portfolio to streamline bioprocessing - MSN
Avantor projects organic revenue growth of negative 2.5% to negative 0.5% for 2026 amid revival program and business resegmentation - MSN
Activist Investor to Push Avantor to Make Changes or Sell Itself - msn.com
Earnings Preview: Avantor to Report Financial Results Pre-market on April 29 - Moomoo
Avantor names Ludovic Brellier as EVP and transformation officer By Investing.com - Investing.com Australia
Avantor® Announces Ludovic Brellier as Executive Vice President, - GuruFocus
Avantor, Inc. Announces Executive Change and Files SEC Form 8-K – April 2026 - Minichart
Yacktman Fund's Avantor Inc(AVTR) Holding History - GuruFocus
Avantor Appoints New Executive VP and Transformation Leader - TipRanks
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avantor Inc Stock (AVTR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| LUCIER GREGORY T | Director |
Feb 19 '26 |
Buy |
9.16 |
50,000 |
458,000 |
50,000 |
| SUMME GREGORY L | Director |
Feb 12 '26 |
Buy |
9.40 |
100,000 |
940,000 |
400,000 |
| MEHRA SANJEEV K | Director |
Dec 05 '25 |
Buy |
11.09 |
350,000 |
3,881,500 |
350,000 |
| Ligner Emmanuel | President and CEO |
Nov 17 '25 |
Buy |
11.35 |
87,500 |
993,125 |
283,424 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):